Your browser doesn't support javascript.
loading
Efficacy and safety of ticagrelor for long-term secondary prevention of atherothrombotic events in relation to renal function: insights from the PEGASUS-TIMI 54 trial.
Magnani, Giulia; Storey, Robert F; Steg, Gabriel; Bhatt, Deepak L; Cohen, Marc; Kuder, Julia; Im, Kyungah; Aylward, Philip; Ardissino, Diego; Isaza, Daniel; Parkhomenko, Alexander; Goudev, Assen R; Dellborg, Mikael; Kontny, Frederic; Corbalan, Ramon; Medina, Felix; Jensen, Eva C; Held, Peter; Braunwald, Eugene; Sabatine, Marc S; Bonaca, Marc P.
Affiliation
  • Magnani G; TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA, USA.
  • Storey RF; Department of Cardiovascular Science, University of Sheffield, Sheffield, UK.
  • Steg G; Cardiology Department, DHU-FIRE, Hôpital Bichat, Paris, France Université Paris-Diderot, Paris, France INSERM U1148, Paris, France.
  • Bhatt DL; TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA, USA.
  • Cohen M; Cardiovascular Division, Department of Medicine, Rutgers-New Jersey Medical School, New York, USA.
  • Kuder J; TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA, USA.
  • Im K; TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA, USA.
  • Aylward P; Division of Medicine, Cardiac & Critical Care Services, Flinders University and Medical Centre, Adelaide, Australia.
  • Ardissino D; Cardiovascular Division, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
  • Isaza D; Fundacion CardioInfantil, Bogota, Colombia.
  • Parkhomenko A; Ukranian Strazhesko Institute of Cardiology, Kiev, Ukraine.
  • Goudev AR; Department of Cardiology, Queen Giovanna University Hospital, Sofia, Bulgaria.
  • Dellborg M; Department of Molecular and Clinical Medicine/Cardiology, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Kontny F; Department of Cardiology, Stavanger University Hospital, Stavanger, Norway.
  • Corbalan R; Cardiovascular Division, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Medina F; Hospital Nacional Cayetano Heredia, San Martin de Porres, Lima, Peru.
  • Jensen EC; AstraZenecaAZ R&D, Molndal, Sweden.
  • Held P; AstraZenecaAZ R&D, Molndal, Sweden.
  • Braunwald E; TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA, USA.
  • Sabatine MS; TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA, USA.
  • Bonaca MP; TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA, USA mbonaca@partners.org.
Eur Heart J ; 37(4): 400-8, 2016 Jan 21.
Article in En | MEDLINE | ID: mdl-26443023
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Coronary Artery Disease / Coronary Thrombosis / Adenosine / Renal Insufficiency, Chronic / Purinergic P2Y Receptor Antagonists / Myocardial Infarction Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Year: 2016 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Coronary Artery Disease / Coronary Thrombosis / Adenosine / Renal Insufficiency, Chronic / Purinergic P2Y Receptor Antagonists / Myocardial Infarction Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Year: 2016 Type: Article